http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100638184-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2001-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100638184-B1 |
| titleOfInvention | Modified Factor Ⅷ |
| abstract | Human factor VIII specific amino acid loci interact with inhibitory antibodies of hemophilia patients after being treated with factor VIII. The modified factor VII is shown where the amino acid sequence is altered by substitution at one or more specific loci. Modified factor VII is useful in hemophilia patients because it avoids or hinders the action of inhibitory antibodies |
| priorityDate | 2000-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1570.